These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 21763383)
1. Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines. Quenee LE; Ciletti NA; Elli D; Hermanas TM; Schneewind O Vaccine; 2011 Sep; 29(38):6572-83. PubMed ID: 21763383 [TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954 [TBL] [Abstract][Full Text] [Related]
3. Complete Protection Against Zhang W; Song X; Zhai L; Guo J; Zheng X; Zhang L; Lv M; Hu L; Zhou D; Xiong X; Yang W Front Immunol; 2022; 13():793382. PubMed ID: 35154110 [TBL] [Abstract][Full Text] [Related]
4. Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague. Cornelius CA; Quenee LE; Overheim KA; Koster F; Brasel TL; Elli D; Ciletti NA; Schneewind O Infect Immun; 2008 Dec; 76(12):5588-97. PubMed ID: 18794281 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680 [TBL] [Abstract][Full Text] [Related]
6. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates. Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642 [TBL] [Abstract][Full Text] [Related]
7. Plague in Guinea pigs and its prevention by subunit vaccines. Quenee LE; Ciletti N; Berube B; Krausz T; Elli D; Hermanas T; Schneewind O Am J Pathol; 2011 Apr; 178(4):1689-700. PubMed ID: 21406168 [TBL] [Abstract][Full Text] [Related]
8. Delivery of Tong Z; Zhang X; Guo X; Wu G; Cao S; Zhang Y; Meng X; Wang T; Wang Y; Song Y; Yang R; Du Z mSphere; 2024 Sep; 9(9):e0033024. PubMed ID: 39158304 [TBL] [Abstract][Full Text] [Related]
9. Plague vaccines and the molecular basis of immunity against Yersinia pestis. Quenee LE; Schneewind O Hum Vaccin; 2009 Dec; 5(12):817-23. PubMed ID: 19786842 [TBL] [Abstract][Full Text] [Related]
10. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles. Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457 [TBL] [Abstract][Full Text] [Related]
11. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague. Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353 [TBL] [Abstract][Full Text] [Related]
13. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734 [TBL] [Abstract][Full Text] [Related]
14. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague. Bowen W; Batra L; Pulsifer AR; Yolcu ES; Lawrenz MB; Shirwan H Vaccine; 2019 Sep; 37(38):5708-5716. PubMed ID: 31416643 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine. Erova TE; Rosenzweig JA; Sha J; Suarez G; Sierra JC; Kirtley ML; van Lier CJ; Telepnev MV; Motin VL; Chopra AK Clin Vaccine Immunol; 2013 Feb; 20(2):227-38. PubMed ID: 23239803 [TBL] [Abstract][Full Text] [Related]
16. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562 [TBL] [Abstract][Full Text] [Related]
17. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. Do Y; Koh H; Park CG; Dudziak D; Seo P; Mehandru S; Choi JH; Cheong C; Park S; Perlin DS; Powell BS; Steinman RM Eur J Immunol; 2010 Oct; 40(10):2791-6. PubMed ID: 20812236 [TBL] [Abstract][Full Text] [Related]
18. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Anderson GW; Leary SE; Williamson ED; Titball RW; Welkos SL; Worsham PL; Friedlander AM Infect Immun; 1996 Nov; 64(11):4580-5. PubMed ID: 8890210 [TBL] [Abstract][Full Text] [Related]
19. Yersinia pestis caf1 variants and the limits of plague vaccine protection. Quenee LE; Cornelius CA; Ciletti NA; Elli D; Schneewind O Infect Immun; 2008 May; 76(5):2025-36. PubMed ID: 18347051 [TBL] [Abstract][Full Text] [Related]
20. Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Alvarez ML; Pinyerd HL; Crisantes JD; Rigano MM; Pinkhasov J; Walmsley AM; Mason HS; Cardineau GA Vaccine; 2006 Mar; 24(14):2477-90. PubMed ID: 16442673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]